نتائج البحث - "Lactate dehydrogenase"

المساهمون: Medical oncology, CCA - Cancer biology and immunology, AII - Cancer immunology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Pathology, Internal Medicine, Psychiatry, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Cancers, 11(12):1940. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 11:WOS:000507382100117. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 11, 12
Schouwenburg, M G, Suijkerbuijk, K P M, Koornstra, R H T, Jochems, A, van Zeijl, M C T, van den Eertwegh, A J M, Haanen, J B A G, Aarts, M J, van Akkooi, A C J, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Kruit, W H, Piersma, D, van Rijn, R S, ten Tije, A J, Vreugdenhil, G, van der Hoeven, J J M & Wouters, M W J M 2019, ' Switching to immune checkpoint inhibitors upon response to targeted therapy; the road to long-term survival in advanced melanoma patients with highly elevated serum LDH? ', Cancers, vol. 11, no. 12, 1940 . https://doi.org/10.3390/cancers11121940Test
Cancers
Cancers, 11(12). Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 11
Cancers, 11(12):1940. MDPI AG

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Cancer Research, Immune checkpoint inhibitors, medicine.medical_treatment, Real-life data, Article, Metastasis, Targeted therapy, Elevated serum, immune checkpoint inhibitors, 03 medical and health sciences, chemistry.chemical_compound, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, real-life data, Lactate dehydrogenase, Internal medicine, medicine, melanoma, metastasis, METASTATIC MELANOMA, PEMBROLIZUMAB, Advanced melanoma, LACTATE-DEHYDROGENASE, OUTCOMES, business.industry, Melanoma, Lactatedehydrogenase, IPILIMUMAB, prognostic factors, NIVOLUMAB, lactate dehydrogenase, medicine.disease, targeted therapy, DABRAFENIB, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Population study, business

وصف الملف: image/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0f5fa3bb8e0ec9098ab93a137bfae3Test
https://cris.maastrichtuniversity.nl/en/publications/31683df4-46fd-4d12-88be-34ddbf9ea021Test

6

Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer

المؤلفون: Dipok Kumar Dhar, Steven W.M. Olde Damink, Massimo Malagó, Pilar Acedo, Goran Mohammad, Vessela Vassileva, Stephen P. Pereira

المساهمون: Surgery, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health

المصدر: Cancers, 11(9):1372. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 11, Iss 9, p 1372 (2019)
Cancers
Cancers 11(9), (2019). doi:10.3390/cancers11091372
Volume 11
Issue 9

مصطلحات موضوعية: 0301 basic medicine, EXPRESSION, Cancer Research, Lactate dehydrogenase A, pancreatic cancer, lactate dehydrogenase A, HYPOXIA, PROGRESSION, PKM2, METABOLISM, lcsh:RC254-282, Article, combination therapy, 03 medical and health sciences, 0302 clinical medicine, In vivo, Pancreatic cancer, medicine, 1112 Oncology and Carcinogenesis, education, chemistry.chemical_classification, education.field_of_study, Science & Technology, Activator (genetics), Chemistry, TUMOR-GROWTH, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 030104 developmental biology, Enzyme, Oncology, GEMCITABINE, Anaerobic glycolysis, 030220 oncology & carcinogenesis, CELLS, Cancer research, OVEREXPRESSION, pyruvate kinase M2, glycolytic enzymes, INHIBITORS, Life Sciences & Biomedicine, Pyruvate kinase